MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

01 Aug 2025 Evaluate
The sales is pegged at Rs. 358.73 millions for the June 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 388.27 millions during the year-ago period.Profit after Tax for the quarter ended June 2025 saw a decline of -31.54% from Rs. 132.37 millions to Rs. 90.62  millions.Operating Profit reported a sharp decline to 141.96 millions from 190.75 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 358.73 388.27 -7.61 358.73 388.27 -7.61 1508.00 1698.22 -11.20
Other Income 2.74 5.24 -47.71 2.74 5.24 -47.71 24.32 43.66 -44.30
PBIDT 141.96 190.75 -25.58 141.96 190.75 -25.58 712.76 831.00 -14.23
Interest 0.42 0.66 -36.36 0.42 0.66 -36.36 3.64 2.29 58.95
PBDT 141.54 190.09 -25.54 141.54 190.09 -25.54 709.12 828.71 -14.43
Depreciation 20.34 11.48 77.18 20.34 11.48 77.18 53.75 35.36 52.01
PBT 121.20 178.61 -32.14 121.20 178.61 -32.14 655.37 793.35 -17.39
TAX 30.58 46.24 -33.87 30.58 46.24 -33.87 167.66 201.71 -16.88
Deferred Tax 5.92 0.53 1016.98 5.92 0.53 1016.98 2.80 3.75 -25.33
PAT 90.62 132.37 -31.54 90.62 132.37 -31.54 487.71 591.64 -17.57
Equity 108.97 72.64 50.01 108.97 72.64 50.01 108.97 72.64 50.01
PBIDTM(%) 39.57 49.13 -19.45 39.57 49.13 -19.45 47.27 48.93 -3.41
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..